Question

Difficulty: MediumTransitions of Care and Handoff Protocols

A 74-year-old man is being discharged to an inpatient rehabilitation facility after a 5-day hospitalization for an acute ischemic stroke. Prior to admission, his home medications included apixaban for nonvalvular atrial fibrillation, lisinopril, and metformin. During his hospital stay, apixaban was temporarily held and he was managed with a prophylactic enoxaparin regimen. On the day of discharge, the attending physician writes a transfer order stating, "Discharge to rehab. Resume all pre-admission home medications. Start rosuvastatin 40 mg daily." The electronic health record automatically generates a list of his home medications and transmits it to the receiving facility along with the discharge summary. Which of the following represents the most critical patient safety vulnerability in this transition of care?

  1. Utilizing a blanket order to resume pre-admission medications without itemized reconciliationAnswer
  2. B
    Omission of explicit if-then contingency plans for potential recurrent neurologic deficits
  3. C
    Transferring the patient to an inpatient rehabilitation facility rather than a skilled nursing facility
  4. D
    Overlooking a major pharmacokinetic interaction between apixaban and the newly prescribed rosuvastatin
  5. E
    Prescribing high-intensity rosuvastatin in the immediate post-acute phase of an ischemic stroke

Answer

The most critical patient safety vulnerability is the use of a blanket order ('resume all pre-admission home medications') without conducting an itemized medication reconciliation.
The use of blanket orders, such as 'resume all pre-admission home medications,' is a highly dangerous practice during care transitions. According to The Joint Commission and standard patient safety frameworks, medication reconciliation must be an active, itemized process where each pre-admission medication is individually reviewed, compared against inpatient orders, and explicitly rewritten or discontinued for the receiving facility. Blanket orders create ambiguity, bypass clinical decision support systems, and frequently lead to adverse drug events such as therapeutic duplication (e.g., receiving both an inpatient anticoagulant and the home anticoagulant) or omission of necessary drugs.

Step-by-Step Solution

1
Analyze the discharge orders provided in the clinical vignette.
The physician wrote 'Resume all pre-admission home medications' alongside a new prescription.
Identifying the exact phrasing of the discharge instructions highlights systemic procedural risks during care transitions.
2
Evaluate the identified phrasing against national patient safety protocols.
Blanket orders for medication resumption violate standard medication reconciliation guidelines.
The Joint Commission and other safety bodies explicitly prohibit blanket orders because they do not force the provider to review each medication individually against the inpatient treatment changes.
3
Assess the potential clinical consequences of this vulnerability.
The patient is at high risk for receiving both enoxaparin (if continued by the rehab) and apixaban, or missing necessary dosage adjustments made during hospitalization.
Transitions between facilities represent the highest risk periods for adverse drug events, making itemized reconciliation critical.

Key Concept

Medication Reconciliation and Avoidance of Blanket Orders
Rate this question